Sign in
4

Changes in Ownership

AbCellera Biologics Inc. Filed Acc 0001628280-25-033735

Options or other derivatives

  • Director acquired 238,864 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Hayden Michael R Director 2025-06-12 Grant or award · Share option (right to buy) +238,864 899,843 D
Loading xslF345X05/wk-form4_1751397189.xml…